There are 383 resources available
102P - Comparison of clinical characteristics and prognosis of incidentally detected and screening detected lung cancers
Presenter: Sungmin Zo
Session: Poster Display session
103P - Effectiveness of artificial intelligence in retrospective COVID-19 lung CT analysis for lung cancer detection
Presenter: Sergei Pirgulov
Session: Poster Display session
104P - The potential for lung cancer detection in COVID-19 CT scans with AI technologies usage
Presenter: Swet Zinovev
Session: Poster Display session
52P - ROS1 aberrations in non-small cell lung cancer patients without rearrangements: Clinical and molecular characteristics
Presenter: Moritz Glaser
Session: Poster Display session
53P - Second line treatment in advanced non-squamous (NS) non-small cell lung cancer (NSCLC) patients in Spain, analyzed in the Thoracic Tumor Registry (RTT)
Presenter: Enric Carcereny Costa
Session: Poster Display session
54P - Overall survival in patients with metastatic lung cancer from 2000 to 2020: Implementation of innovative strategies in a real-world setting
Presenter: Clemence Basse
Session: Poster Display session
55P - The impact of liquid next-generation testing timing on treatment-naïve advanced non-small cell lung cancer: A prospective observational study
Presenter: CHINGYAO YANG
Session: Poster Display session
56P - Simultaneous tissue and liquid next-generation sequencing after first-line EGFR tyrosine kinase inhibitors resistance in advanced non-small cell lung cancer
Presenter: Yen-Ting Lin
Session: Poster Display session
57P - Acquired concurrent EGFR T790M and driver gene resistance from EGFR-TKIs hampered osimertinib efficacy in advanced lung adenocarcinoma
Presenter: Fang Wu
Session: Poster Display session
58P - A predictive model of the diagnostic value of next generation sequencing based genomics testing in patients with metastatic non-small cell lung cancer in Spain
Presenter: Alba Mota
Session: Poster Display session